Article

Kenneth Freundlich on the Importance of Advocacy for Patients With Hereditary Cancers

Author(s):

Kenneth Freundlich

Kenneth Freundlich, neuropsychologist, Morris Psychological Group, Parsippany, NJ, and FORCE volunteer, discusses the importance of advocacy for patients with hereditary cancers.

Kenneth Freundlich, neuropsychologist, Morris Psychological Group, Parsippany, NJ, and FORCE volunteer, discusses the importance of advocacy for patients with hereditary cancers.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of two doctors and text.
Image of man.
Image of thumbnail.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of woman.
Image of two people.
Image of doctor.
Image of woman.
Related Content
Image of Patti.
June 12th 2025

Beyond Treatment: How Support Groups Helped Me Embrace My New Normal

Patti McGee
Joining support groups after cancer treatment helped me heal emotionally, connect with others who understood and embrace a new, meaningful normal.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Brenda Denzler is a writer and editor living in North Carolina. She was diagnosed with inflammatory breast cancer in 2009. Catch up on Brenda’s blogs here.
June 10th 2025

A Letter to My 2009 Self, Newly Diagnosed With Breast Cancer

Brenda Denzler
I survived breast cancer and medical trauma, but the road was brutal. Fifteen years later, I’m alive, scarred and still searching for peace.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of ovaries.
June 10th 2025

FDA Grants Fast Track Status to PHST001 for Ovarian Cancer Treatment

Spencer Feldman
The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and platinum-sensitive ovarian cancer.
Martha Carlson received a diagnosis of metastatic breast cancer in 2015. Read all of Martha's blogs here!
June 9th 2025

The Gift of a Good Cancer Nurse

Martha Carlson
When it comes to living with cancer, your nurses make a difference.